EPG Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.41M Sell
4,792
-607
-11% -$615K 1.2% 19
2025
Q4
$5.8M Sell
5,399
-24
-0.4% -$22.9K 1.56% 16
2025
Q3
$4.14M Buy
5,423
+491
+10% +$365K 1.14% 20
2025
Q2
$3.84M Buy
4,932
+203
+4% +$158K 1.15% 19
2025
Q1
$3.91M Sell
4,729
-116
-2% -$96.5K 1.09% 18
2024
Q4
$3.74M Sell
4,845
-475
-9% -$393K 0.99% 19
2024
Q3
$4.71M Buy
+5,320
New +$4.78M 1.19% 15
2024
Q2
Sell
-6,009
Closed -$4.81M 14
2024
Q1
$4.67M Buy
6,009
+180
+3% +$128K 1.14% 16
2023
Q4
$4.33M Sell
5,829
-141
-2% -$82.3K 1.14% 16
2023
Q3
$3.21M Sell
5,970
-184
-3% -$94.8K 0.97% 18
2023
Q2
$2.89M Buy
6,154
+136
+2% +$57K 0.85% 20
2023
Q1
$2.07M Buy
6,018
+2,576
+75% +$869K 0.65% 30
2022
Q4
$1.26M Sell
3,442
-653
-16% -$232K 0.48% 47
2022
Q3
$1.32M Buy
4,095
+96
+2% +$30.4K 0.54% 38
2022
Q2
$1.3M Sell
3,999
-25
-0.6% -$7.5K 0.55% 43
2022
Q1
$1.15M Buy
4,024
+353
+10% +$90.8K 0.4% 56
2021
Q4
$1.01M Buy
3,671
+119
+3% +$30.2K 0.36% 63
2021
Q3
$821K Buy
3,552
+114
+3% +$28.1K 0.33% 67
2021
Q2
$789K Buy
3,438
+172
+5% +$34.5K 0.33% 72
2021
Q1
$610K Buy
3,266
+417
+15% +$81.6K 0.3% 76
2020
Q4
$481K Buy
2,849
+1,327
+87% +$198K 0.29% 77
2020
Q3
$225K Buy
+1,522
New +$236K 0.17% 113
2020
Q2
Sell
-619
Closed -$86K 498
2020
Q1
$86K Buy
619
+205
+50% +$28.2K 0.06% 192
2019
Q4
$54K Buy
+414
New +$48K 0.04% 227

Other funds holding LLY

EPG Wealth Management's LLY Position: Q1 2026 in Review

EPG Wealth Management reduced its Eli Lilly (LLY) stake by 11% in Q1 2026, selling an estimated $615K and leaving 4,792 shares worth $4.41M. The position accounts for 1.2% of the portfolio, ranked #19.

EPG Wealth Management first reported a position in LLY in Q4 2019 and has held it in 24 quarters since. The position peaked at $5.8M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • EPG Wealth Management held 4,792 shares of Eli Lilly worth $4.41M as of Q1 2026.
  • EPG Wealth Management sold 607 Eli Lilly shares in Q1 2026, an estimated $615K.
  • Eli Lilly made up 1.2% of EPG Wealth Management's portfolio in Q1 2026, its #19 holding.
  • EPG Wealth Management first reported a position in Eli Lilly in Q4 2019 and has held it in 24 quarters since.
  • EPG Wealth Management's Eli Lilly position peaked at $5.8M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on EPG Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.